Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
45
about 8.5 years
18+
Female only
2 sites in AZ, MN
What this study is about
Researchers are testing if radiotherapy can delay a change in systemic therapy for breast cancer patients whose disease has progressed. The trial will also collect samples from participants' blood to help guide treatment decisions.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Stereotactic Body Radiation Therapy (SBRT)
- 2.Surveys
- 3.Undergo Biospecimen Collection
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Freedom from a change in systemic therapy (FCST) - ER+/PR±/HER2- (Subgroup A), Overall survival (OS), Progression-free survival (PFS), Quality of life - EQ-5D-5L
diagnostic, imaging
Oncology